Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04000217 · ClinicalTrials.gov registry record · NA
Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy
A NA study of Written Exposure Therapy and Imaginal Exposure Therapy, sponsored by Palo Alto Veterans Institute for Research.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT04000217: Completed NA study of Written Exposure Therapy and Imaginal Exposure Therapy, sponsored by Palo Alto Veterans Institute for Research.
NCT04000217 is a NA study of Written Exposure Therapy and Imaginal Exposure Therapy that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04000217, a NA study of Written Exposure Therapy and Imaginal Exposure Therapy, has completed, sponsored by Palo Alto Veterans Institute for Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare the efficacy of two different versions of a brief online exposure therapy program for PTSD: written versus verbal trauma narrative recounting in reducing PTSD symptom severity. Both treatments will be delivered through an interactive online program with coaching from a trained peer support specialist. Treatment will be a variable length, such that 4 to 8 sessions will be delivered, depending on each participants' rate of PTSD symptom recovery.
Primary Outcome
Self report measure of PTSD symptoms. A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items. Higher scores indicate greater PTSD severity.
Conditions Studied
Interventions
- BEHAVIORAL Written Exposure Therapy
- BEHAVIORAL Imaginal Exposure Therapy
Study Locations (1)
Illinois
- Prevail Health Inc. - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2020-01-20 |
| Est. Completion | 2022-09-09 |
| Phase | NA |
What the finished NCT04000217 record still lists
NCT04000217 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Written Exposure Therapy appearing as the primary indexed condition, and to 2 interventions - of which Written Exposure Therapy is the first listed.
NCT04000217 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04000217 about?
NCT04000217 is a clinical study titled "Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy". The purpose of the study is to compare the efficacy of two different versions of a brief online exposure therapy program for PTSD: written versus verbal trauma narrative recounting in reducing PTSD symptom severity. Both treatments will be delivered through an interactive online program with coachin...
What is the current status of trial NCT04000217?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2020-01-20. Estimated completion is 2022-09-09.
What conditions does trial NCT04000217 study?
This clinical trial studies the following conditions: Written Exposure Therapy, Imaginal Exposure Therapy.
What interventions are being tested in trial NCT04000217?
The interventions under investigation include: Written Exposure Therapy (BEHAVIORAL), Imaginal Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04000217?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04000217 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04000217's enrollment target sits among peer trials
130 733rd of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI